Liraglutide Dosage Guide: Daily GLP-1 Protocol & Reconstitution Explained
Liraglutide
Liraglutide is a GLP-1 receptor agonist studied for appetite control, blood sugar regulation, and fat loss. It mimics the GLP-1 hormone, helping regulate hunger, slow gastric emptying, and improve metabolic function.
How It Works
GLP-1 Activation ↑ → Appetite ↓ → Blood Sugar Control ↑ → Gastric Emptying ↓ → Fat Loss Support
Liraglutide works by activating GLP-1 receptors, signaling fullness, reducing food intake, and supporting glucose regulation. Unlike longer-acting GLP-1 compounds, it requires daily administration.
Liraglutide Protocol
5 mg vial + 2.0 mL BAC Water → 1 unit = 25 mcg → Daily GLP-1 Support
Standard / Gradual Titration
5 mg vial reconstituted with 2.0 mL bacteriostatic water
1 unit = 25 mcg
Week 1
Starting Dose
Dose0.6 mg daily
Units24 units
FrequencyOnce daily
Week 2
Build
Dose1.2 mg daily
Units48 units
FrequencyOnce daily
Week 3+
Standard Range
Dose1.8 mg daily
Units72 units
FrequencyOnce daily
Simple structure:
Liraglutide is a daily GLP-1 agonist, so dosing is slowly increased over time to improve tolerance and reduce nausea, appetite drop-off, and GI side effects.
Liraglutide is a daily GLP-1 agonist, so dosing is slowly increased over time to improve tolerance and reduce nausea, appetite drop-off, and GI side effects.
How to Use Liraglutide (Cycle, Timing & Injection)
FrequencyOnce daily
TimingSame time each day
RouteSubcutaneous
Cycle LengthOngoing use, not typically cycled
Best Time to Inject
Morning or evening can both work.
Use at the same time daily for consistency.
Can be taken with or without food.
If nausea occurs, timing can be adjusted based on tolerance.
Where to Inject
Subcutaneous injection is the standard route discussed.
Common sites include abdomen, thigh, or upper arm.
Rotate injection sites regularly to reduce irritation.
When to Use
During appetite-control phases
During fat-loss or glucose-regulation support phases
When daily GLP-1 activity is preferred over weekly dosing
As a gradual titration-based protocol rather than a fast dose jump
Simple Strategy
Titrate Slowly
Liraglutide is usually increased gradually because GI tolerance is one of the biggest limiting factors.
Daily Consistency
Because liraglutide is shorter acting than weekly GLP-1 compounds, daily consistency matters.
Real-World vs Clinical Use
Real-World Use
Typical Range0.6–1.8 mg daily
GoalFat loss + appetite control
Clinical / Medical Context
Use CaseType 2 diabetes + obesity
RealityDose titrated to tolerance
Reconstitution & Dosing
Reconstitution & Dosing
Vial5 mg
Water2.0 mL
Concentration2.5 mg/mL
Conversion1 unit = 25 mcg
Dose Reference
24 units = 0.6 mg
48 units = 1.2 mg
72 units = 1.8 mg
Reconstitution Steps
Draw 2.0 mL bacteriostatic water
Inject slowly into vial or down the vial wall
Gently swirl, do not shake
Allow powder to fully dissolve before use
Refrigerate after reconstitution
Important:
Unit math depends on vial size and water volume. This example uses a 5 mg vial with 2.0 mL added, creating a clean 1 unit = 25 mcg conversion.
Unit math depends on vial size and water volume. This example uses a 5 mg vial with 2.0 mL added, creating a clean 1 unit = 25 mcg conversion.
Storage & Shelf Life
Storage & Shelf Life
Lyophilized (unmixed)
Refrigerated (2–8°C): ~12–24 months
Frozen (−20°C): up to ~2–3 years
Store sealed, dry, and protected from light
Reconstituted (mixed)
Refrigerated (2–8°C): about 30 days typical use window
Do not freeze after mixing
Avoid repeated temperature changes
Best Practice
Handling
Keep the vial cold, protected from light, and limit unnecessary handling.
Visual Check
If the solution becomes cloudy, discolored, or contains visible particles, it is safer not to continue using it.
Time Between Cycles
Daily GLP-1 Use → Monitor Response → Adjust Based on Goals + Tolerance
Cycle Context
Use StyleOngoing use, not typically cycled
Review PointEvery 8–12 weeks
BreaksBased on tolerance, goals, and response
Why this is different:
Liraglutide is not usually treated like a short peptide cycle. It is a daily GLP-1 medication-style compound, so use is typically based on appetite response, weight trends, blood sugar response, and GI tolerance rather than a fixed on/off cycle.
Liraglutide is not usually treated like a short peptide cycle. It is a daily GLP-1 medication-style compound, so use is typically based on appetite response, weight trends, blood sugar response, and GI tolerance rather than a fixed on/off cycle.
When to Reassess
Nausea or GI discomfort becomes difficult to manage
Appetite suppression is too strong or too weak
Weight-loss progress stalls for an extended period
Blood sugar response needs closer monitoring
Dose increases are being considered too quickly
Common Mistakes
Increasing too quickly before GI tolerance is stable
Not staying hydrated
Not prioritizing protein intake during appetite suppression
Skipping daily doses inconsistently
Monitoring During Use
Appetite suppression
Weight loss progress
Blood sugar response
GI tolerance
Benefits
Reduces appetite
Supports fat loss
Improves blood sugar control
Slows gastric emptying
Potential Side Effects
Nausea, especially during titration
Vomiting or GI discomfort
Reduced appetite, which can be strong
Fatigue during adjustment
Important Notes
Daily dosing required, unlike semaglutide
Titrate slowly to reduce side effects
Often used long-term
Hydration and protein intake are important
Important Disclaimer
Liraglutide is a prescription medication and not FDA-approved for all uses. This content is for educational purposes only.
Comments
Post a Comment